FGFR2 and Apert syndrome: If mutant receptors are homogeneously distributed throughout the facial and neurocranial regions of the skulls of Apert syndrome mouse models, a net increase in the length and strength of Fgfr2 signaling may be responsible for the increased level of integration within the face, within the neurocranium, as well as between the face and the neurocranium.